Statements: IMPERIO PHARMA MEDICAMENTOS LTDA.

Canonical ID: br-ceis-3bc0c4dcfee2ceee9bcac2669b2cae627230d16b · Entity type: Company (reference)

This table shows statement-based, sourced records from our database. For more context, learn about how OpenSanctions stores information.

Property	Value	Source dataset	Source ID	First seen
`Company:country`	br	br_ceis	`br-ceis-3bc0c4dcfee2ceee9bcac2669b2cae627230d16b`	2024-10-02
`Company:id`	22f77883e04e1d48e8976f75f099c6cb20d2cbd3	br_ceis	`br-ceis-3bc0c4dcfee2ceee9bcac2669b2cae627230d16b`	2026-02-14
`Company:id`	ae6e1040138d85ecb7bfef38d76db7749b304662	br_ceis	`br-ceis-3bc0c4dcfee2ceee9bcac2669b2cae627230d16b`	2026-02-13
`Company:name`	IMPERIO PHARMA MEDICAMENTOS LTDA.	br_ceis	`br-ceis-3bc0c4dcfee2ceee9bcac2669b2cae627230d16b`	2026-02-14
`Company:name`	IMPÉRIO PHARMA MEDICAMENTOS LTDA	br_ceis	`br-ceis-3bc0c4dcfee2ceee9bcac2669b2cae627230d16b`	2026-02-13
`Company:programId`	BR-CEIS	br_ceis	`br-ceis-3bc0c4dcfee2ceee9bcac2669b2cae627230d16b`	2025-09-12
`Company:taxNumber`	43595813000184	br_ceis	`br-ceis-3bc0c4dcfee2ceee9bcac2669b2cae627230d16b`	2024-10-02
`Company:topics`	debarment	br_ceis	`br-ceis-3bc0c4dcfee2ceee9bcac2669b2cae627230d16b`	2024-10-02